Sphingolipid Metabolism in Drosophila Development
果蝇发育中的鞘脂代谢
基本信息
- 批准号:8423071
- 负责人:
- 金额:$ 32.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-09-01 至 2015-02-28
- 项目状态:已结题
- 来源:
- 关键词:ActinsAddressAdultAnimal ModelApoptosisAtrophicAutophagocytosisBacterial InfectionsBiochemicalBiochemistryBiologicalBiological ModelsBiologyCardiomyopathiesCatabolismCell LineCell ProliferationCell SurvivalCell modelCellsCellular Stress ResponseCellular biologyChemicalsChestComplexDefectDevelopmentDifferentiation and GrowthDiseaseDrosophila genusDrosophila melanogasterDynaminDystroglycanEndocytosisEngineeringEnzymesEukaryotaEventEvolutionExtracellular MatrixFamilyGene ExpressionGene TargetingGeneticGoalsGrantGrowthGrowth and Development functionHomeostasisHybridsInflammationInheritedInjuryInsulin ResistanceInvestigationKnockout MiceLipidsLyaseMaintenanceMalignant NeoplasmsMedicalMembraneMembrane BiologyMembrane FusionMembrane ProteinsMetabolic syndromeMetabolismMolecularMolecular TargetMusMuscleMuscle CellsMuscle DevelopmentMuscle FibersMuscular AtrophyMuscular DystrophiesMusculoskeletal DiseasesMyoblastsMyogeninMyopathyMyosin Heavy ChainsNatural regenerationNeurodegenerative DisordersOrganPI3K/AKTPathologyPathway interactionsPatternPhenocopyPhenotypePhosphorylationPhysiologicalPlayProcessProductionProtein BiosynthesisProtein-Lysine 6-OxidaseProteinsProto-Oncogene Proteins c-aktResearchRodent ModelRoleSPHK1 enzymeSarcolemmaSignal TransductionSignaling MoleculeSignaling ProteinSkeletal MuscleSphinganine-1-phosphate aldolaseSphingolipidsSphingosine-1-Phosphate ReceptorStriated MusclesSystemTestingTimeTissuesTranslationsVertebral columnVirus DiseasesWasting SyndromeWorkage relatedbasecancer therapyembryo tissueenzyme activityexperienceflyfrailtygene therapyhuman diseaseimmune functionmigrationmuscle regenerationmuscular dystrophy mouse modelmutantnovelpre-clinicalpreventprotein expressionpublic health relevanceresponsesatellite cellsphingosine 1-phosphatesphingosine kinasesphingosine-1-phosphate lyase
项目摘要
DESCRIPTION (provided by applicant): Sphingolipids are a conserved family of lipids built upon a sphingoid base backbone. Sphingolipids serve structural membrane functions, whereas their metabolism produces signaling molecules involved in regulating mammalian development, immune function, inflammation and cellular stress responses. Studies supported by this grant have explored the role of sphingolipids in the model organism Drosophila melanogaster. These studies have resulted in the chemical characterization of Drosophila sphingoid bases and the identification of novel endogenous Drosophila sphingolipids with potent growth-inhibitory activity. Further, we have shown that Sply mutants lacking expression of Drosophila sphingosine-1-phosphate (S1P) lyase (SPL), which is responsible for the final step of sphingolipid degradation, accumulate sphingolipid intermediates and develop a progressive myopathy in the thoracic muscles needed to power flight. The Sply myopathy is corrected by reducing sphingolipid production, indicating sphingolipid intermediates play a causative role. We have observed that mutants in key membrane proteins such as dynamin and dystroglycan phenocopy the Sply myopathy. We have also conducted cell-based investigations that suggest that Sply/SPL is required for normal AKT signaling, protein translation, myoblast fusion, myoblast gene expression and control of autophagy. Many of these interactions have been corroborated in murine C2C12 cells, indicating that SPL plays a conserved role in myoblast survival, fusion and differentiation. We have also found that sphingosine kinase and S1P lyase are dynamically upregulated during murine muscle regeneration, leading to a transient peak in S1P levels in regenerating muscle. These collective observations have led us to propose our central hypothesis, which states that SPL plays a critical role in muscle biology, development and homeostasis. The specific aims of our proposal are, thus: 1) To define the role of SPL in muscle cell biology; 2) To dissect the role of SPL in muscle development; and 3) To establish the role of SPL in muscle atrophy and regeneration. Our long-term goals are to exploit Drosophila to elucidate the role of sphingolipids in biology, membrane function, and tissue homeostasis and to define the relevance of these findings to human disease. Due to species-specific structural differences in sphingolipids and the lack of S1P receptors in lower eukaryotes, we do not expect the two systems to be equivalent. Thus, our goals are to compare the biochemical and molecular events associated with SPL loss in Drosophila and murine cell and animal models, with the intent of developing a comprehensive understanding of how SPL functions in the context of muscle tissue and how its function may have been modified throughout evolution. These studies should be readily achieved by our team, which has extensive experience in sphingolipid biochemistry, Drosophila genetics, and the genetics and pathology of MD.
描述(由申请人提供):鞘脂是建立在鞘脂底座上的脂质家族。鞘脂具有结构性膜功能,而它们的代谢产生参与调节哺乳动物发育,免疫功能,炎症和细胞应激反应的信号分子。该赠款支持的研究探索了鞘脂在模型有机体果蝇中的作用。这些研究导致了果蝇鞘脂碱的化学表征,并鉴定出具有有效的生长活性的新型内源性果蝇鞘脂。此外,我们已经表明,缺乏果蝇鞘氨醇1-磷酸(S1P)裂解酶(SPL)表达的Sply突变体负责鞘脂降解的最后一步,积累了鞘脂的中间体,并在需要进行动力飞行的胸肌肌肉中产生了渐进性肌病。通过减少鞘脂的产生来纠正SPLY肌病,表明鞘脂中间体起因作用。我们已经观察到关键膜蛋白中的突变体(例如dynamin和Dystroglycan苯并copicy sply肌病)。我们还进行了基于细胞的研究,表明正常AKT信号传导,蛋白质翻译,成肌细胞融合,成肌细胞基因表达和自噬的控制所必需。这些相互作用中的许多相互作用已在鼠C2C12细胞中证实,表明SPL在成肌细胞存活,融合和分化中起着保守的作用。我们还发现,在鼠肌肉再生过程中,鞘氨醇激酶和S1P裂解酶动态上调,导致在再生肌肉中S1P水平的短暂峰。这些集体观察结果使我们提出了我们的中心假设,该假设指出,SPL在肌肉生物学,发育和稳态中起着至关重要的作用。因此,我们提案的具体目的是:1)定义SPL在肌肉细胞生物学中的作用; 2)剖析SPL在肌肉发育中的作用; 3)确定SPL在肌肉萎缩和再生中的作用。我们的长期目标是利用果蝇,以阐明鞘脂在生物学,膜功能和组织稳态中的作用,并确定这些发现与人类疾病的相关性。由于物种特异性的结构差异在鞘脂脂质以及较低的真核生物中缺乏S1P受体的情况下,我们不希望这两个系统是等效的。因此,我们的目标是比较与果蝇和鼠类细胞和动物模型中SPL损失相关的生化和分子事件,以便对SPL在肌肉组织的背景下的功能以及在整个进化过程中如何修改其功能的全面了解。这些研究应很容易由我们的团队来实现,该研究在鞘脂生物化学,果蝇遗传学以及MD的遗传学和病理方面具有丰富的经验。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
S1P lyase in skeletal muscle regeneration and satellite cell activation: exposing the hidden lyase.
- DOI:10.1016/j.bbalip.2012.06.009
- 发表时间:2013-01
- 期刊:
- 影响因子:0
- 作者:Saba JD;de la Garza-Rodea AS
- 通讯作者:de la Garza-Rodea AS
A facile stable-isotope dilution method for determination of sphingosine phosphate lyase activity.
- DOI:10.1016/j.chemphyslip.2015.09.006
- 发表时间:2016-01
- 期刊:
- 影响因子:3.4
- 作者:Suh JH;Eltanawy A;Rangan A;Saba JD
- 通讯作者:Saba JD
Sphingosine 1-phosphate lyase ablation disrupts presynaptic architecture and function via an ubiquitin- proteasome mediated mechanism.
- DOI:10.1038/srep37064
- 发表时间:2016-11-24
- 期刊:
- 影响因子:4.6
- 作者:Mitroi DN;Deutschmann AU;Raucamp M;Karunakaran I;Glebov K;Hans M;Walter J;Saba J;Gräler M;Ehninger D;Sopova E;Shupliakov O;Swandulla D;van Echten-Deckert G
- 通讯作者:van Echten-Deckert G
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JULIE D SABA其他文献
JULIE D SABA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JULIE D SABA', 18)}}的其他基金
Validating absolute lymphocyte count and plasma sphingosine-1-phosphate as disease biomarkers of sphingosine phosphate lyase insufficiency syndrome in anticipation of a pyridoxine clinical trial
验证绝对淋巴细胞计数和血浆 1-磷酸鞘氨醇作为磷酸鞘氨醇裂解酶不足综合征的疾病生物标志物,以期待吡哆醇临床试验
- 批准号:
10515118 - 财政年份:2022
- 资助金额:
$ 32.2万 - 项目类别:
Validating absolute lymphocyte count and plasma sphingosine-1-phosphate as disease biomarkers of sphingosine phosphate lyase insufficiency syndrome in anticipation of a pyridoxine clinical trial
验证绝对淋巴细胞计数和血浆 1-磷酸鞘氨醇作为磷酸鞘氨醇裂解酶不足综合征的疾病生物标志物,以期待吡哆醇临床试验
- 批准号:
10705139 - 财政年份:2022
- 资助金额:
$ 32.2万 - 项目类别:
Endogenous and Dietary Sphingolipids as Modulators in Inflammatory Bowel Disease
内源性和膳食鞘脂作为炎症性肠病的调节剂
- 批准号:
10222659 - 财政年份:2018
- 资助金额:
$ 32.2万 - 项目类别:
Agilent 6490 Triple Quadrupole Mass Spectrometer
Agilent 6490 三重四极杆质谱仪
- 批准号:
8640509 - 财政年份:2014
- 资助金额:
$ 32.2万 - 项目类别:
IVIS Spectrum small animal imaging system
IVIS Spectrum 小动物成像系统
- 批准号:
8447251 - 财政年份:2013
- 资助金额:
$ 32.2万 - 项目类别:
FASEB SRC on Lysophospholipd Mediators in Health and Disease
FASEB SRC 关于健康和疾病中的溶血磷脂介质
- 批准号:
8203973 - 财政年份:2011
- 资助金额:
$ 32.2万 - 项目类别:
Endogenous sphingosine-1-phosphate as a radioprotector of intestinal tissues
内源性 1-磷酸鞘氨醇作为肠道组织的辐射保护剂
- 批准号:
8010757 - 财政年份:2010
- 资助金额:
$ 32.2万 - 项目类别:
Soy sphingadienes and related compounds in colon cancer chemoprevention and treat
大豆鞘氨醇及相关化合物在结肠癌的化学预防和治疗中的作用
- 批准号:
7916337 - 财政年份:2009
- 资助金额:
$ 32.2万 - 项目类别:
Soy sphingadienes and related compounds in colon cancer chemoprevention and treat
大豆鞘氨醇及相关化合物在结肠癌的化学预防和治疗中的作用
- 批准号:
7713515 - 财政年份:2009
- 资助金额:
$ 32.2万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
EGF Receptor Endocytosis: Mechanisms and Role in Signaling
EGF 受体内吞作用:机制及其在信号传导中的作用
- 批准号:
10552100 - 财政年份:2023
- 资助金额:
$ 32.2万 - 项目类别:
Mechanical signaling through the nuclear membrane in lung alveolar health
通过核膜的机械信号传导影响肺泡健康
- 批准号:
10677169 - 财政年份:2023
- 资助金额:
$ 32.2万 - 项目类别:
Characterizing Wnt Signaling Pathways in Axon Guidance
轴突引导中 Wnt 信号通路的特征
- 批准号:
10815443 - 财政年份:2023
- 资助金额:
$ 32.2万 - 项目类别:
ArpC3-mediated actin remodeling in insulin granule exocytosis and diabetes
ArpC3 介导的肌动蛋白重塑在胰岛素颗粒胞吐作用和糖尿病中的作用
- 批准号:
10583734 - 财政年份:2023
- 资助金额:
$ 32.2万 - 项目类别:
Hypertrophic adipocytes as biophysical mediators of breast cancer progression
肥大脂肪细胞作为乳腺癌进展的生物物理介质
- 批准号:
10751284 - 财政年份:2023
- 资助金额:
$ 32.2万 - 项目类别: